# Phase 1 Study of the Safety and Pharmacokinetics of YN001 With Rosuvastatin in Healthy Chinese Subjects

> **NCT07309042** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Beijing Inno Medicine Co., Ltd.** · enrollment: 24 (estimated)

## Conditions studied

- Atherosclerotic Cardiovascular Diseases
- Cerebrovascular Diseases

## Interventions

- **DRUG:** YN001, Rosuvastatin calcium Tablets
- **DRUG:** YN001, Rosuvastatin calcium Tablets
- **DRUG:** YN001, Rosuvastatin calcium Tablets

## Key facts

- **NCT ID:** NCT07309042
- **Lead sponsor:** Beijing Inno Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2026-02
- **Final completion:** 2026-02
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07309042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07309042, "Phase 1 Study of the Safety and Pharmacokinetics of YN001 With Rosuvastatin in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07309042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*